Vimarsana
Biggest News Aggregation in the World

Stem Cell Biology Programme News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stem Cell Biology Programme. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stem Cell Biology Programme Today - Breaking & Trending Today

Can the Zika vaccine fight brain cancer? - Vimarsana News

Can the Zika vaccine fight brain cancer?

New research potentially offers a new treatment alternative for brain cancer patients who currently have a poor prognosis.

Duke-NUS appoints Prof Patrick Tan as Senior - Vimarsana News

Duke-NUS appoints Prof Patrick Tan as Senior

Duke-NUS Medical School has appointed Professor Patrick Tan to the leadership role of Senior Vice-Dean (Designate) for Research, effective from 1 May 2023. He takes over from Professor Patrick Casey, who is stepping down after having led the School’s research efforts since its inception in 2005. Prof Tan will also assume the role of Senior Scientific Advisor at SingHealth, where he will be pivotal in strengthening the relationship between SingHealth and Duke-NUS in research and innovation, as part of the two organisations’ academic medicine partnership. Both roles will be fully effective f...

Measuring telomeres could reveal how fast you're aging - Vimarsana News

Measuring telomeres could reveal how fast you're aging

A new approach that "baits" the caps or telomeres could provide info on how rapidly we're aging and what we need to do to slow it down.

Singapore to revolutionise therapeutics for cancer & infectious diseases - Vimarsana News

Singapore to revolutionise therapeutics for cancer & infectious diseases

Duke-NUS, Xylonix join forces to improve effectiveness of Xylonix cancer drugs

Researchers conduct first-in-man clinical trial for new stem cell technology - Vimarsana News

Researchers conduct first-in-man clinical trial for new stem cell technology

Institutes and centres under the SingHealth Duke-NUS Academic Medical Centre (AMC) are joining hands together with Singapore's first private cord blood bank, Cordlife Group Limited (Cordlife), to test a novel technology that expands the number of blood-forming stem cells from stored umbilical cord blood (UCB) in a first-in-man study in Singapore.